Oroscomucoid 3 (ORMDL3), a gene localized to chromosome 17q21, has been linked in epidemiologic studies to childhood asthma and rhinoviral (RV) infections. As the single nucleotide polymorphisms linking ORMDL3 to asthma is associated with increased expression of ORMDL3, we have utilized hORMDL3zp3-Cre mice (which have universal increased expression of human ORMDL3) to determine whether infection of these transgenic mice with RV influences levels of airway inflammation or RV viral load. RV infection of hORMDL3zp3-Cre mice resulted in reduced RV viral load assessed by RT-qPCR (lung and airway epithelium), as well as reduced airway inflammation (total BAL cells, neutrophils, macrophages, and lymphocytes) compared to RV infected WT mice. Levels of the anti-viral pathways including interferons (IFNα, IFNβ, IFNλ) and RNAse L were significantly increased in the lungs of RV infected hORMDL3zp3-Cre mice. Levels of the anti-viral mouse oligo-adenylate synthetase 1g (mOas1g) pathway and RNAse L were upregulated in the lungs of unchallenged hORMDL3zp3-Cre mice. In addition, levels of mOas2, but not mOas1 (mOas1a, mOas1b, mOas1g), or mOas3 pathways were significantly more upregulated by IFNs (IFNα, IFNβ, IFNλ) in epithelial cells from hORMDL3zp3-Cre mice compared to RV infected WT mouse epithelial cells. RNAse L deficient mice infected with RV had increased RV viral load. Overall, these studies suggest that increased levels of ORMDL3 contribute to antiviral defense to RV infection in mice through pathways that may include interferons (IFNα, IFNβ, IFNλ), OAS, and RNAse L.